US5061254A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Thermoplastic elastomeric hydrophilic polyetherurethane expandable catheter
Assignee: Superior Healthcare Group Inc
•
Filing: 1990-03-26
•
Granted: 1991-10-29
•
Expires: 2010-03-26
Abstract
Abstract A melt extruded catheter of thermoplastic elastomeric hydrophilic polyurethane synthesized from a diisocyanate, polyethyleneoxide glycol of high molecular weight and a chain extender expands to a larger lumen size when contacted with an aqueous liquid. The catheter may include an antithrombogenic agent, antiinfective agent and radiopaque agent. The hydrophilic polyurethane may be synthesized by one-shot bulk polymerization, and may be melt extruded into the catheter tubing, and may encapsulate a stripe of a stiffening polyurethane.
Inventors
- 👤 Mutlu Karakelle
- 👤 Donald D. Solomon
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 04:04
CPC Classifications
C; C08; C08G; C08G18/00; C08G18/06; C08G18/28; C08G18/65; C08G18/66; C08G18/6666; C08G18/667; C08G18/6674; A; A61; A61L; A61L29/00; A61L29/04; A61L29/06; A61L29/14; A61L29/16; A61L29/18; A61M; A61M25/00; A61M25/0009; C08G18/40; C08G18/48; C08G18/4833; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/406; A61L2300/42
Claims Analysis
Total Claims: 26
Claim 1
Independent Claim
97 words
A melt extruded catheter comprising a substantially hydrophilic thermoplastic elastomeric polyurethane tubing, said polyurethane having a hard segment of 25 to 60% and comprising the product from reaction of a mixture of a diisocyanate, a chain extender and a polyglycol component comprising from 80 to 100% of polyethyleneoxide glycol wherein the ratio of said diisocyanate to said combined polyglycol and extender components is about 1.02:1, said tubing, when brought into contact with an aqueous liquid, absorbing about 10 to 200% of its weight of said liquid and expanding whereby its inside diameter increases about 5 to 75%.
Claim 2
Dependent Claim
97 words
A melt extruded catheter comprising a substantially hydrophilic thermoplastic elastomeric polyurethane tubing, said polyurethane having a hard segment of 25 to 60% and comprising the product from reaction of a mixture of a diisocyanate, a chain extender and a polyglycol component comprising from 80 to 100% of polyethyleneoxide glycol wherein the ratio of said diisocyanate to said combined polyglycol and extender components is about 1.02:1, said tubing, when brought into contact with an aqueous liquid, absorbing about 10 to 200% of its weight of said liquid and expanding whereby its inside diameter increases about 5 to 75%.
Claim 3
Dependent Claim
24 words
The catheter of claim 1 wherein said diisocyanate is selected from the group consisting of 4,4'-diphenylmethane diisocyanate, 3,3'-diphenylmethane diisocyanate, isophorone diisocyanate and hexamethylene diisocyanate.
Claim 4
Dependent Claim
36 words
The catheter of claim 1 wherein said chain extender is selected from the group consisting of 1-4-butanediol, ethylene glycol, diethylene glycol, triethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,6-hexanediol, 1,4-bis hydroxymethyl cyclohexane, hydroquinone dihydroxyethyl ether, ethanolamine, ethylenediamine and hexamethylenediamine.
Claim 5
Dependent Claim
18 words
The catheter of claim 1 wherein said polyethyleneoxide glycol has a molecular weight of about 650 to 16,000.
Claim 6
Dependent Claim
29 words
The catheter of claim 1 wherein said thermoplastic elastomeric hydrophilic polyurethane further comprises a polyglycol selected from the group consisting of polypropyleneoxide glycol, polytetramethyleneoxide glycol and a silicone glycol.
Claim 7
Dependent Claim
25 words
The catheter of claim 1 further comprising an agent selected from the group consisting of an antiinfective agent, a radiopaque agent and an antithrombogenic agent.
Claim 8
Dependent Claim
26 words
The catheter of claim 6 wherein said antithrombogenic agent is selected from the group consisting of a prostaglandin, urokinase, streptokinase, tissue plasminogen activator and a heparinoid.
Claim 9
Dependent Claim
22 words
The catheter of claim 6 wherein said antiinfective agent is selected from the group consisting of chlorhexidine, silver sulfadiazine and an antibiotic.
Claim 10
Dependent Claim
24 words
The catheter of claim 6 wherein said radiopaque agent is selected from the group consisting of an inorganic radiopaque and an iodinated organic radiopaque.
Claim 11
Dependent Claim
95 words
A melt extruded catheter comprising a substantially hydrophilic thermoplastic elastomeric polyurethane tubing, said polyurethane having a hard segment of about 30 to 45% and comprising the product from reaction of 4,4'-diphenylmethane diisocyanate, 1,4-butanediol and polyglycol fraction consisting essentially of polyethyleneoxide glycol of molecular weight from about 600 to about 8,000 wherein the ratio of said diisocyanate to said combined polyglycol and 1,4-butanediol is about 1.02:1, said tubing, when brought into contact with an aqueous liquid, absorbing about 50 to 100% of its weight of said liquid and expanding whereby its inside diameter increases about 25%.
Claim 12
Dependent Claim
95 words
A melt extruded catheter comprising a substantially hydrophilic thermoplastic elastomeric polyurethane tubing, said polyurethane having a hard segment of about 30 to 45% and comprising the product from reaction of 4,4'-diphenylmethane diisocyanate, 1,4-butanediol and polyglycol fraction consisting essentially of polyethyleneoxide glycol of molecular weight from about 600 to about 8,000 wherein the ratio of said diisocyanate to said combined polyglycol and 1,4-butanediol is about 1.02:1, said tubing, when brought into contact with an aqueous liquid, absorbing about 50 to 100% of its weight of said liquid and expanding whereby its inside diameter increases about 25%.
Claim 13
Dependent Claim
114 words
A melt extruded catheter comprising a substantially hydrophilic thermoplastic elastomeric base polyurethane tubing encapsulating a stripe of a stiffening polyurethane, said base polyurethane having a hard segment of 25% to 65% and comprising the product from reaction of a mixture of a first diisocyanate, a first chain extender and a first polyglycol component, said second polyglycol component comprising at least 50% of polyethyleneoxide glycol, said stiffening polyurethane comprising the reaction product of a second diisocyanate, a second chain extender and a second polyglycol component, said second polyglycol component consisting essentially of polytetramethyleneoxide glycol, said stiffening polyurethane having a hard segment content of 50 to 90% and a water absorption of no more than 10%.
Claim 14
Dependent Claim
114 words
A melt extruded catheter comprising a substantially hydrophilic thermoplastic elastomeric base polyurethane tubing encapsulating a stripe of a stiffening polyurethane, said base polyurethane having a hard segment of 25% to 65% and comprising the product from reaction of a mixture of a first diisocyanate, a first chain extender and a first polyglycol component, said second polyglycol component comprising at least 50% of polyethyleneoxide glycol, said stiffening polyurethane comprising the reaction product of a second diisocyanate, a second chain extender and a second polyglycol component, said second polyglycol component consisting essentially of polytetramethyleneoxide glycol, said stiffening polyurethane having a hard segment content of 50 to 90% and a water absorption of no more than 10%.
Claim 15
Dependent Claim
27 words
The catheter of claim 11 wherein said first and second diisocyanates are selected from the group consisting of 4,4'-diphenylmethane diisocyanate, 3,3'-diphenylmethane diisocyanate, isophorone diisocyanate and hexamethylene diisocyanate.
Claim 16
Dependent Claim
37 words
The catheter of claim 11 wherein said first and second chain extenders are selected from the group consisting of 1-4-butanediol, ethylene glycol, diethylene glycol, triethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,6-hexanediol, 1,4-bis-hydroxymethyl cyclohexane, hydroquinone dihydroxyethyl ether, ethanolamine, ethylenediamine and
Claim 17
Dependent Claim
18 words
The catheter of claim 11 wherein said polyethyleneoxide glycol has a molecular weight of about 650 to 16,000.
Claim 18
Dependent Claim
27 words
The catheter of claim 11 wherein said base polyurethane further comprises a polyglycol selected from the group consisting of polypropyleneoxide glycol, polytetramethyleneoxide glycol and a silicone glycol.
Claim 19
Dependent Claim
29 words
The catheter of claim 11 wherein said base polyurethane further comprises an agent selected from the group consisting of an antiinfective agent, a radiopaque agent and an antithrombogenic agent.
Claim 20
Dependent Claim
26 words
The catheter of claim 16 wherein said antithrombogenic agent is selected from the group consisting of a prostaglandin, urokinase, streptokinase, tissue plasminogen activator and a heparinoid.
Claim 21
Dependent Claim
22 words
The catheter of claim 16 wherein said antiinfective agent is selected from the group consisting of chlorhexidine, silver sulfadiazine and an antibiotic.
Claim 22
Dependent Claim
24 words
The catheter of claim 16 wherein said radiopaque agent is selected from the group consisting of an inorganic radiopaque and an iodinated organic radiopaque.
Claim 23
Dependent Claim
109 words
A melt extruded catheter comprising a substantially hydrophilic thermoplastic elastomeric base polyurethane tubing encapsulating a stripe of a stiffening polyurethane, said base polyurethane having a hard segment of 30 to 45% and comprising the product from reaction of a mixture of 4,4'-diphenylmethane diisocyanate, 1-4-butanediol, and a polyglycol component comprising at least 50% of polyethyleneoxide glycol having a molecular weight of 6,000 to 12,000, said stiffening polyurethane comprising the reaction product of 4,4'-diphenylmethane diisocyanate, 1,4-butanediol and polytetramethyleneoxide glycol said tubing when brought into contact with an aqueous liquid absorbing about 50 to 150% of its weight of said liquid and expanding whereby its inside diameter increases about 5 to 50%.
Claim 24
Dependent Claim
109 words
A melt extruded catheter comprising a substantially hydrophilic thermoplastic elastomeric base polyurethane tubing encapsulating a stripe of a stiffening polyurethane, said base polyurethane having a hard segment of 30 to 45% and comprising the product from reaction of a mixture of 4,4'-diphenylmethane diisocyanate, 1-4-butanediol, and a polyglycol component comprising at least 50% of polyethyleneoxide glycol having a molecular weight of 6,000 to 12,000, said stiffening polyurethane comprising the reaction product of 4,4'-diphenylmethane diisocyanate, 1,4-butanediol and polytetramethyleneoxide glycol said tubing when brought into contact with an aqueous liquid absorbing about 50 to 150% of its weight of said liquid and expanding whereby its inside diameter increases about 5 to 50%.
Claim 25
Dependent Claim
18 words
The catheter of claim 20 wherein said stiffening polymer has a hard segment content of 50 to 90%.
Claim 26
Dependent Claim
18 words
The catheter of claim 20 wherein said stiffening polymer has a water absorption of no more than 10%.
References Cited (Backward Citations)
US4371686A
Cited
US4424305A
Cited
US4454309A
Cited
US4780512A
Cited
US4883699A
Cited
US4689386A
Cited
US4678660A
Cited
US4668221A
Cited
US4790817A
Cited
US4781703A
Cited
US4647643A
Cited
US4798876A
Cited
US4810582A
Cited
US4728322A
Cited
US4798597A
Cited
US4789720A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-10-28 | 1995-04-29 | 1995-10-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-10-28 | 1999-04-29 | 1999-10-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-10-28 | 2003-04-29 | 2003-10-29 | $7700.00 | Window Closed / Lapsed |